Physician profile
Michael C Edelstein
NPI 1376546853
$1,489.67
in general payments reported to CMS, 2019-2025
8 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $273 · 2021: $264 · 2022: $374 · 2023: $125 · 2024: $313 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $349.78 | 2022-2024 | Nuzyra |
| Horizon Therapeutics Plc | $252.86 | 2020-2022 | |
| Smith+Nephew, INC. | $230.98 | 2021-2025 | Oasis, Grafix |
| Abbott Laboratories | $212.47 | 2024 | Proclaim |
| Integra Lifesciences Corporation | $144.96 | 2020 | |
| Bioventus LLC | $125.00 | 2023 | Exogen Ultrasound Bone Healing System |
| Medela LLC | $91.70 | 2021 | |
| Advanced Oxygen Therapy INC. | $81.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Edelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.